Mon, September 9, 2019
Fri, September 6, 2019
Thu, September 5, 2019
Wed, September 4, 2019
Tue, September 3, 2019
Fri, August 30, 2019
Thu, August 29, 2019
Wed, August 28, 2019
Tue, August 27, 2019
Mon, August 26, 2019
Fri, August 23, 2019
Thu, August 22, 2019
Wed, August 21, 2019
Tue, August 20, 2019
Mon, August 19, 2019
Fri, August 16, 2019
Thu, August 15, 2019
Wed, August 14, 2019
Tue, August 13, 2019
Mon, August 12, 2019
Fri, August 9, 2019

Charles Duncan Reiterated (ACAD) at Buy with Increased Target to $40 on, Aug 27th, 2019

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-40-on-aug-27th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Charles Duncan of Cantor Fitzgerald, Reiterated "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $30 to $40 on, Aug 27th, 2019.

Charles has made no other calls on ACAD in the last 4 months.



There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Charles's Rating of Hold.



This is the rating of the analyst that currently disagrees with Charles


  • Danielle Brill of "Raymond James" Reiterated at Strong Buy with Increased Target to $43 on, Friday, May 31st, 2019